International Biotechnology Trust PLC Kal Vista Pharmaceuticals, Inc. Transaction History

International Biotechnology Trust PLC

$295 Million
Q3 2023

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$9.85 - $16.83 $3.08 Million - $5.26 Million	312,373 Added 8307.79%	316,133 $4.59 Million
Q2 2022 Aug 16, 2022	SELL	$8.16 - $15.1 $3.1 Million - $5.73 Million	-379,473 Reduced 99.02%	3,760 $383 Million
Q3 2021 Nov 12, 2021	BUY	$17.11 - $24.49 $1.71 Million - $2.45 Million	100,000 Added 35.31%	383,233 $6.69 Million
Q2 2021 Aug 11, 2021	BUY	$23.12 - $29.91 $1.59 Million - $2.05 Million	68,700 Added 32.02%	283,233 $6.79 Million
Q1 2021 May 17, 2021	BUY	$14.69 - $42.57 $544,999 - $1.58 Million	37,100 Added 20.91%	214,533 $5.49 Million
Q2 2020 Jul 14, 2020	SELL	$6.75 - $12.89 $337,500 - $644,500	-50,000 Reduced 21.98%	177,433 $2.25 Million
Q1 2020 May 18, 2020	SELL	$5.8 - $18.56 $290,000 - $927,999	-50,000 Reduced 18.02%	227,433 $1.73 Million
Q4 2019 May 18, 2020	BUY	$10.31 - $17.81 $1.03 Million - $1.78 Million	100,000 Added 56.36%	277,433 $4.92 Million
Q3 2019 Nov 14, 2019	SELL	$11.6 - $21.67 $117,925 - $220,297	-10,166 Reduced 5.42%	177,433 $2.06 Million
Q2 2019 Aug 14, 2019	SELL	$18.44 - $30.89 $469,519 - $786,521	-25,462 Reduced 11.95%	187,599 $4.17 Million
Q1 2019 May 14, 2019	SELL	$16.51 - $31.1 $1.76 Million - $3.31 Million	-106,383 Reduced 33.3%	213,061 $6.06 Million
Q4 2018 Feb 14, 2019	SELL	$16.21 - $24.06 $48,500 - $71,987	-2,992 Reduced 0.93%	319,444 $4.95 Million
Q3 2018 Nov 14, 2018	BUY	$8.0 - $22.11 $1.75 Million - $4.84 Million	218,936 Added 211.53%	322,436 $5.47 Million
Q3 2018 Nov 13, 2018	SELL	$8.0 - $22.11 $1.75 Million - $4.84 Million	-218,936 Reduced 67.9%	103,500 $766,000
Q4 2016 Mar 02, 2018	BUY	N/A	322,436	322,436 $2.19 Million

Others Institutions Holding KALV

# of Institutions

125

Shares Held

47.8M

Call Options Held

551K

Put Options Held

110K

Vr Adviser, LLC New York, NY

6.25M
Shares

$56 Million
7.5% of portfolio
Tang Capital Management LLC San Diego, CA

4.32M
Shares

$38.7 Million
4.26% of portfolio
Suvretta Capital Management, LLC New York, NY

4.21M
Shares

$37.7 Million
1.92% of portfolio
Vestal Point Capital, LP New York, NY

4M
Shares

$35.8 Million
3.51% of portfolio
Frazier Life Sciences Management, L.P. Menlo Park, CA

3.69M
Shares

$33 Million
2.3% of portfolio

View Full List

About KalVista Pharmaceuticals, Inc.

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $220M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

More about KALV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

News

Stay updated on International Biotechnology Trust PLC with notifications on news.

Account